tiprankstipranks
Advertisement
Advertisement

CRDF Stock Latest News

Analyst Reiterates Buy on Cardiff Oncology, Maintains $10 Price Target Ahead of Key ASCO Data for Onvansertib
RatingsAnalyst Reiterates Buy on Cardiff Oncology, Maintains $10 Price Target Ahead of Key ASCO Data for Onvansertib
8h ago
CRDF
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
PremiumCompany Announcements
Cardiff Oncology Files Lawsuit Over Onvansertib Patent Rights
9d ago
8K
CRDF
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
PremiumRatings
Cardiff Oncology Wins Buy Rating on Strong Phase 2 Efficacy, FDA-Aligned Phase 3 Path, and Broader Onvansertib Combination Potential
14d ago
CRDF
Cardiff Oncology reports Q1 EPS (18c), consensus (12c)
PremiumThe Fly
Cardiff Oncology reports Q1 EPS (18c), consensus (12c)
14d ago
CRDF
Cardiff Oncology sees cash, equivalents funding operations into 1Q27
PremiumThe Fly
Cardiff Oncology sees cash, equivalents funding operations into 1Q27
14d ago
CRDF
CRDF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsCRDF Upcoming Earnings Report: What to Expect?
1M ago
CRDF
Cardiff Oncology to present preclinical data on onvansertib
Premium
The Fly
Cardiff Oncology to present preclinical data on onvansertib
1M ago
CRDF
Cardiff Oncology appoints new CEO, CFO and COO
Premium
Company Announcements
Cardiff Oncology appoints new CEO, CFO and COO
2M ago
8K
CRDF
Cardiff Oncology appoints Mani Mohindru CEO, Josh Muntner CFO
PremiumThe Fly
Cardiff Oncology appoints Mani Mohindru CEO, Josh Muntner CFO
2M ago
ACRS
CRDF
Cardiff Oncology Formalizes Executive Departures Amid Strategic Review
PremiumCompany Announcements
Cardiff Oncology Formalizes Executive Departures Amid Strategic Review
2M ago
8K
CRDF
Cardiff Oncology advances onvansertib program in colorectal cancer
PremiumCompany Announcements
Cardiff Oncology advances onvansertib program in colorectal cancer
3M ago
8K
CRDF
Cardiff Oncology price target lowered to $6 from $10 at Piper Sandler
PremiumThe Fly
Cardiff Oncology price target lowered to $6 from $10 at Piper Sandler
3M ago
CRDF
Cardiff Oncology: Promising Onvansertib Data and Solid Cash Runway Support Buy Rating and $10 Price Target
PremiumRatingsCardiff Oncology: Promising Onvansertib Data and Solid Cash Runway Support Buy Rating and $10 Price Target
3M ago
CRDF
CRDF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CRDF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CRDF
Cardiff Oncology selloff brings attractive entry point, says H.C. Wainwright
Premium
The Fly
Cardiff Oncology selloff brings attractive entry point, says H.C. Wainwright
4M ago
CRDF
Cardiff Oncology Overhauls Leadership to Advance Onvansertib
PremiumCompany Announcements
Cardiff Oncology Overhauls Leadership to Advance Onvansertib
4M ago
8K
CRDF
Balancing Leadership Turmoil and Focused Clinical Strategy: Maintaining a Buy on Cardiff Oncology’s Onvansertib Amid Catalyst-Rich Outlook
PremiumRatings
Balancing Leadership Turmoil and Focused Clinical Strategy: Maintaining a Buy on Cardiff Oncology’s Onvansertib Amid Catalyst-Rich Outlook
4M ago
CRDF
Cardiff Oncology announces CEO Erlander, CFO Levine have stepped down
PremiumThe Fly
Cardiff Oncology announces CEO Erlander, CFO Levine have stepped down
4M ago
CRDF
Cardiff Oncology announces update from CRDF-004, Phase 2 trial of onvansertib
PremiumThe Fly
Cardiff Oncology announces update from CRDF-004, Phase 2 trial of onvansertib
4M ago
CRDF
Cardiff Oncology initiated with an Outperform at Noble Capital
PremiumThe FlyCardiff Oncology initiated with an Outperform at Noble Capital
5M ago
CRDF
Cardiff Oncology: Promising Clinical Results and Strong Financial Position Justify Buy Rating
Premium
Ratings
Cardiff Oncology: Promising Clinical Results and Strong Financial Position Justify Buy Rating
7M ago
CRDF
Cardiff Oncology Reports Increased Losses Amid Ongoing Trials
Premium
Company Announcements
Cardiff Oncology Reports Increased Losses Amid Ongoing Trials
7M ago
CRDF

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >